Sun BioPharma Inc (SNBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sun BioPharma Inc (SNBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH395544D
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company's pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti-tumor activity in human cancer cell lines and is used for the treatment of patients with pancreatic ductal adenocarcinoma. Sun BioPharma's SBP-102 is used for the treatment of patients with pancreatitis. The company offers clinical trials and drug development services. It partners with institutions, universities, cancer centers and research centers for the development of drugs. Sun BioPharma is headquartered in Waconia, Minnesota, the US.

Sun BioPharma Inc (SNBP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Sun BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Sun BioPharma Raises USD1.5 Million in Venture Financing 11

Sun BioPharma Raises USD2 Million in Venture Financing 12

Sun Biopharma Raises USD 3 Million In Venture Financing 13

Sun BioPharma Raises USD 2.32 Million In Venture Financing 14

Sun BioPharma Raises USD 0.55 Million In Seed Financing 15

Merger 16

Cimarron Medical Merges with Sun BioPharma in Reverse Merger Transaction 16

Equity Offering 17

Sun BioPharma Raises USD0.8 Million in Private Placement of Shares and Securities 17

Sun Biopharma Files Registration Statement to Raise up to USD19.37 Million in Public Offering of Shares 18

Sun BioPharma Plans to Raise Funds through Public Offering of Shares 19

Sun BioPharma Raises Funds in Private Placement of Shares and Warrants 20

Sun BioPharma Raises USD0.2 in Private Placement of Shares and Warrants 21

Sun BioPharma Raises USD2 Million in Private Placement of Shares and Warrants 22

Sun Biopharma Raises USD0.4 Million in Private Placement of Shares up on Exercise of Warrants 23

Sun Biopharma Raises USD1.2 Million in Private Placement of Shares 24

Sun Biopharma Raises USD0.02 Million in Private Placement of Shares up on Exercise of Warrants 25

Debt Offering 26

Sun BioPharma Raises USD3 Million in Private Placement of 5% Notes Due 2018 26

Sun BioPharma Raises USD3.1 Million in Private Placement of 5% Notes Due 2018 27

Sun BioPharma Inc-Key Competitors 28

Sun BioPharma Inc-Key Employees 29

Sun BioPharma Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Aug 13, 2018: Sun BioPharma Provides a Business Update and Files Report for Q2 2018 31

May 14, 2018: Sun BioPharma Reports Financial Report For Q1 2018 33

Mar 21, 2018: Sun BioPharma Provides Business Update and Files Annual Report for 2017 35

Nov 14, 2017: Sun BioPharma Files Form 10-Q for Third Quarter 2017 and Provides Business Update 37

Aug 10, 2017: Sun BioPharma reports financial results for the second quarter 2017 39

May 11, 2017: Sun BioPharma Reports First Quarter 2017 Results 40

Mar 30, 2017: Sun BioPharma Announces Financial Report of Year End December 2016 42

Mar 30, 2017: Sun BioPharma Q4 net loss increases 43

Product News 44

02/01/2017: The NIH Awards Sun BioPharma Grant to Study SBP-101 for the Treatment of Pancreatitis 44

Clinical Trials 45

Feb 22, 2018: Sun Biopharma Files United States Patent Protecting the Manufacturing Process for Its Lead Drug Candidate, SBP-101 45

Jan 29, 2018: Sun Biopharma Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer 46

Oct 04, 2017: Sun BioPharma Achieves Significant Milestone with Successful Completion of Patient Enrollment in Phase 1a Dose Escalation Safety Study of SBP-101 for Patients with Pancreatic Cancer 47

Aug 10, 2017: Sun BioPharma Provides Clinical Update 49

Jun 05, 2017: Sun BioPharma Announces Completion of the Fifth Patient Cohort in the Dose Escalation Phase 1a Study of SBP-101 for Pancreatic Cancer 50

Mar 30, 2017: Sun BioPharma Provides Phase 1 Trial Update on SBP-101 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Figures

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

List of Tables

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Sun BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Sun BioPharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sun BioPharma Raises USD1.5 Million in Venture Financing 11

Sun BioPharma Raises USD2 Million in Venture Financing 12

Sun Biopharma Raises USD 3 Million In Venture Financing 13

Sun BioPharma Raises USD 2.32 Million In Venture Financing 14

Sun BioPharma Raises USD 0.55 Million In Seed Financing 15

Cimarron Medical Merges with Sun BioPharma in Reverse Merger Transaction 16

Sun BioPharma Raises USD0.8 Million in Private Placement of Shares and Securities 17

Sun Biopharma Files Registration Statement to Raise up to USD19.37 Million in Public Offering of Shares 18

Sun BioPharma Plans to Raise Funds through Public Offering of Shares 19

Sun BioPharma Raises Funds in Private Placement of Shares and Warrants 20

Sun BioPharma Raises USD0.2 in Private Placement of Shares and Warrants 21

Sun BioPharma Raises USD2 Million in Private Placement of Shares and Warrants 22

Sun Biopharma Raises USD0.4 Million in Private Placement of Shares up on Exercise of Warrants 23

Sun Biopharma Raises USD1.2 Million in Private Placement of Shares 24

Sun Biopharma Raises USD0.02 Million in Private Placement of Shares up on Exercise of Warrants 25

Sun BioPharma Raises USD3 Million in Private Placement of 5% Notes Due 2018 26

Sun BioPharma Raises USD3.1 Million in Private Placement of 5% Notes Due 2018 27

Sun BioPharma Inc, Key Competitors 28

Sun BioPharma Inc, Key Employees 29

Sun BioPharma Inc, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sun BioPharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17500
Site License
USD 500 INR 35000
Corporate User License
USD 750 INR 52500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com